Cowen Healthcare Investments has led a funding round for Scipher Medicine, co-founded by Harvard Medical School colleagues Joseph Loscalzo and Albert-László Barabási.

Scipher Medicine, a US-based precision immunology company, has raised $110m in a funding round led by Cowen Healthcare Investments.

Hitachi Ventures and Optum Ventures, respective investment arms of conglomerate Hitachi and healthcare company Optum, also took part in the round, which was filled out by Neuberger Berman, Laurion Capital, Monashee Investment Management, Northpond Ventures, aMoon, Khosla Ventures, Echo Innovation Alliance and Alumni Ventures.

Founded in 2014, Scipher Medicine has developed a platform that uncovers a patient’s unique molecular disease signature and identifies the most effective treatment for their autoimmune condition using blood tests.

The molecular and clinical data generated through the tests is then also used to drive the discovery and development of more effective therapeutics through partnerships with pharmaceutical firms.

Scipher Medicine was co-founded by Joseph Loscalzo, head of the Department of Medicine at Brigham & Women’s Hospital, a teaching hospital of Harvard University’s Medical School, and Albert-László…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).